71 related articles for article (PubMed ID: 8495215)
1. p-Bromophenacyl bromide potentiates hydrogen peroxide formation in human platelets challenged by thrombin and inhibits aggregation.
Leoncini G; Aprile B; Maresca M
Biochem Mol Biol Int; 1993 Feb; 29(2):317-25. PubMed ID: 8495215
[TBL] [Abstract][Full Text] [Related]
2. N-ethylmaleimide inhibits platelet aggregation and potentiates hydrogen peroxide formation induced by thrombin.
Leoncini G
Biochem Mol Biol Int; 1994 Aug; 34(1):119-26. PubMed ID: 7849614
[TBL] [Abstract][Full Text] [Related]
3. Interference of bromophenacyl bromide with platelet phospholipase A2 activity induced by thrombin and by the ionophore A23187.
Vargaftig BB; Fouque F; Chignard M
Thromb Res; 1980 Jan 1-15; 17(1-2):91-102. PubMed ID: 6246654
[No Abstract] [Full Text] [Related]
4. Carrageenan-induced activation of human platelets is independent of phospholipase A2 and of formation of thromboxanes.
Vargaftig BB; Fouque F; Chignard M; Dumarey C
J Pharm Pharmacol; 1980 Nov; 32(11):740-5. PubMed ID: 6110720
[TBL] [Abstract][Full Text] [Related]
5. Effects of methylglyoxal on platelet hydrogen peroxide accumulation, aggregation and release reaction.
Leoncini G; Poggi M
Cell Biochem Funct; 1996 Jun; 14(2):89-95. PubMed ID: 8640957
[TBL] [Abstract][Full Text] [Related]
6. Preferential activation of phospholipase A2 by low concentrations of phosphatidic acid with long-chain fatty acids in rabbit platelets.
Sato T; Hashizume T; Fujii T
J Biochem; 1992 Dec; 112(6):756-61. PubMed ID: 1295883
[TBL] [Abstract][Full Text] [Related]
7. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of thrombin and SFLLR-peptide stimulation of platelet aggregation, phospholipase A2 and Na+/H+ exchange by a thrombin receptor antagonist.
Seiler SM; Peluso M; Michel IM; Goldenberg H; Fenton JW; Riexinger D; Natarajan S
Biochem Pharmacol; 1995 Feb; 49(4):519-28. PubMed ID: 7872957
[TBL] [Abstract][Full Text] [Related]
9. YD-3, a novel inhibitor of protease-induced platelet activation.
Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of A23187-induced arachidonic acid liberation by vasopressin is sensitive to genistein in rabbit platelets.
Akiba S; Sato T; Fujii T
Biochem Mol Biol Int; 1993 Sep; 31(1):135-42. PubMed ID: 8260937
[TBL] [Abstract][Full Text] [Related]
11. Carrageenan and thrombin trigger prostaglandin synthetase-independent aggregation of rabbit platelets: inhibition by phospholipase A2 inhibitors.
Vargaftig BB
J Pharm Pharmacol; 1977 Apr; 29(4):222-8. PubMed ID: 17672
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory and platelet anti-aggregant activity of phospholipase-A2 inhibitors.
Vallee E; Gougat J; Navarro J; Delahayes JF
J Pharm Pharmacol; 1979 Sep; 31(9):588-92. PubMed ID: 41058
[TBL] [Abstract][Full Text] [Related]
13. [Chemiluminescence of thrombocytes in thrombin-induced aggregation].
Samal' AB; Cherenkevich SN; Khmara NF
Vopr Med Khim; 1984; 30(6):12-5. PubMed ID: 6442039
[TBL] [Abstract][Full Text] [Related]
14. Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein.
Sabetkar M; Naseem KM; Tullett JM; Friebe A; Koesling D; Bruckdorfer KR
Nitric Oxide; 2001 Jun; 5(3):233-42. PubMed ID: 11384196
[TBL] [Abstract][Full Text] [Related]
15. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide.
Pignatelli P; Pulcinelli FM; Celestini A; Lenti L; Ghiselli A; Gazzaniga PP; Violi F
Am J Clin Nutr; 2000 Nov; 72(5):1150-5. PubMed ID: 11063442
[TBL] [Abstract][Full Text] [Related]
16. Platelet aggregation following exposure of phospholipase-treated platelet rich plasma to hydrogen peroxide.
Iatridis SG; Iatridis PG; Kyrkou KA; Markidou SG; Iatridi IS
Thromb Res; 1979; 15(5-6):733-41. PubMed ID: 494174
[No Abstract] [Full Text] [Related]
17. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
[TBL] [Abstract][Full Text] [Related]
18. Influence of platelet activating factor antagonists on the protamine sulphate stimulated release of histamine from peritoneal mast cells of rats in vitro.
Lohde C; Bahr T; Labes D; Grupe R
Arzneimittelforschung; 1992 Jan; 42(1):27-31. PubMed ID: 1375025
[TBL] [Abstract][Full Text] [Related]
19. The effects of mepacrine and p-bromophenacyl bromide on arachidonic acid release in human platelets.
Hofmann SL; Prescott SM; Majerus PW
Arch Biochem Biophys; 1982 Apr; 215(1):237-44. PubMed ID: 6807207
[No Abstract] [Full Text] [Related]
20. Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: evidence that both effects are coupled to adenylate cyclase.
Paul S; Feoktistov I; Hollister AS; Robertson D; Biaggioni I
Mol Pharmacol; 1990 Jun; 37(6):870-5. PubMed ID: 2359405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
